Communications / 04 March 2024
We take a deep dive into the world of serious and unexpected adverse events, termed 'black swan' events, and their profound impact on drug safety, healthcare, and patient care.
Serious and unexpected adverse drug reactions – the ‘black swans’ of pharmacovigilance – can place enormous strain on safety monitoring systems. Drawing examples from the COVID-19 pandemic, François Montastruc from Toulouse University Hospital explains how we can get better at dealing with the unexpected.
Subscribe by visiting the Drug Safety Matters website or listen to the podcast here:
Uppsala Reports editor
@UMCGlobalSafety
The partnership seeks to improve the interoperability of CDISC standards and WHODrug Global for more effective sharing and use of medicinal product safety data.
Communications / 20 February 2024
The latest WHO PIDM film celebrates the long-standing collaboration between WHO and UMC to fulfil the mission of making medicines and vaccines safer for everyone.
Communications / 11 March 2024
With the misinformation pandemic still rife on the internet, finding websites with scientifically accurate vaccine information is quite the task. The VSN aims to change that.
Communications / 17 June 2024
